Fullscreen

  • Interaction of TU/PHI pharmacist with TB Care ecosystem

    Content

    Pharmacists remain the first and only health care provider that patients utilize. Pharmacists can thus play an important role in facilitating optimal pathways to the care of tuberculosis (TB), a disease which affects over 9 million individuals every year. 

     The Peripheral Health Institution (PHI) Pharmacists’ contributions as ‘drug-dispensers’, that is to provide physician-prescribed treatment to notified TB patients, or at best to serve as treatment supervisors under the DOT (directly observed therapy) framework

     

    Pharmacists can contribute to TB care and control in several ways (Fig. 1)

    Description: https://www.atlantis-press.com/assets/articles/JEGH-7-1-1/JEGH-7-1-1-g001.jpg

     

     

     

     

     

     

     

     

     

     

     

     

     

    Interaction with laboratory managers for the laboratory supplies to   DMCs, NAAT Sites and C&DST Labs .

    Interaction with the programme officer for the stock updates at various level (The District TB Centre, TB Unit )

     

    Resource

    NTEP TrainingModules 5to9  Central TB Division, MoHFW, GoI 2020

     

    Assessment:

    Question​

    Answer 1​

    Answer 2​

    Answer 3​

    Answer 4​

    Correct answer​

    Correct explanation​

    Page id​

    Part of Pre-test​

    Part of Post-test​

    A TU/PHI pharmacist interacts with medical officer at ART centre

    True

    False

     

     

    1

    With Anti Retroviral Therapy (ART) centre  medical officer for the supply of TB drugs for the TB-HIV patient

     

     

     

     

     

     

     

     

  • Role of Treatment Supporter in SCM

    Content

    Ensuring adherence to correct treatment is crucial in the outcome of tuberculosis and hence it is essential to develop a patient-centred approach to treatment administration.

    • A Treatment Supporter (TS) who is acceptable and accessible to the patient as well as accountable to the health system should be identified in consultation with the patient during pre-treatment evaluation.
    • The TS can either be a healthcare worker, community worker/ volunteer or private practitioner or family member.
    • If a family member is identified as TS s/he should be trained to give medication under supervision at the residence, under close monitoring by Community Health Officer (CHO)/ Accredited Social Health Activist (ASHA)/ Auxilliary Nurse Midwife (ANM)/ Multipurpose Workers (MPW) with support from Tuberculosis Health Visitor (TBHV)/ Senior Treatment Supervisor (STS).

     

    Role of TS in Supply Chain Management

    • Whenever a patient is initiated on treatment, the monthly patient-wise boxes are issued to the TS of the patient.
    • In the case of Bedaquiline (Bdq) since the treatment is initiated at the Nodal/ District DR-TB Centre (N/DDR-TBC), on discharge, the patient is issued the remaining bottle of Bdq drug, which is then handed over to the TS.
    • In the case of Delamanid (Dlm), on discharge from the N/DDR TBC the remaining drugs for the rest of the first month are issued to the patient which is then handed over to the TS.
    • In any case, TS is responsible for issuing the medicines to the patient on a daily basis until the end of the course, thereby ensuring Direct Observation of Treatment (DOT).
    • The TS are also responsible for collecting/ receiving month-wise boxes throughout the treatment duration of the patient.
    • The TS is assigned to the Ni-kshay database with respect to the particular patient and issued a Treatment Card to maintain a record of all drugs consumed by the patient.
    • In case of death/ loss to follow-up/ discontinuation of treatment due to any reason or in case of change/ modification of the regimen, the TS is responsible for returning the issued patient wise box back to the treatment centre and also ensuring that the new/modified regimen box is issued to the patient.

     

    Resources

    1. Standard Operating Procedure Manual Procurement & Supply Chain Management, CTD, MoHFW, India, 2018.
    2. Procurement, Supply Chain Management & Preventive Maintenance, Module 6, CTD, MoHFW, India.
    3. Direct Benefi­t Transfer Manual for National Tuberculosis Elimination Programme, Central TB Division, Ministry of Health & Family Welfare, India, 2021.

     

    Assessment

    Question​ Answer 1​ Answer 2​ Answer 3​ Answer 4​ Correct answer​ Correct explanation​ Page id​ Part of Pre-test​ Part of Post-test​
    In the case of Delamanid (Dlm), on discharge from the N/DDR TBC the remaining drugs for the rest of the first month are issued to the patient, which is then handed over to the TS. True False            1 In the case of Delamanid (Dlm), on discharge from the N/DDR TBC the remaining drugs for the rest of the first month are issued to the patient which is then handed over to the TS. ​ Yes Yes